Context Therapeutics
NASDAQ: CNTX
$0.38
as on
Context Therapeutics Stock Performance
as on August 29, 2026 at 2:15 pm IST
Day's High
$0.38$0.4210.53%
Upside
52 Week's Low
52 Week's High
$0.38$3.62
-0.18%
Downside
852.63%
Upside
Context Therapeutics share price movements today
- Previous Close
- $0.42
- Open
- $0.42
- Volume
- 4.5M
- Market Cap
- $38.2M
- Day's Low - High
- $0.38 - $0.42
- 52 Week Low - High
- $0.38 - $3.62
Context Therapeutics Historical Returns
- 1 Month Return
- -35.99 %
- 3 Month Return
- -86.54 %
- 1 Year Return
- -54.32 %
- 3 Year Return
- -62.75 %
- 5 Year Return
- 0 %
Context Therapeutics Stock Fundamentals & Key Indicators
Check Context Therapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$38.2M
EPS (TTM)
-0.4812
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-0.9
Industry PE ratio
-1.5868503937007874
PEG Ratio
0.03267605166035002
EBITDA
-45.9M
Revenue (TTM)
-
Profit Margin
0.00%
Return On Equity TTM
-82.06%
Context Therapeutics Stock Valuation
Track how Context Therapeutics P/E has moved over time to understand its valuation trends.
Context Therapeutics in the last 5 years
Lowest (-3.87x)
December 31, 2025
Today (-3.87x)
December 31, 2025
Industry (-1.59x)
December 31, 2025
Highest (-0.70x)
December 31, 2022
Today’s Price to Earnings Ratio: -3.87x
Context Therapeutics vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Context Therapeutics with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % | Dividend Yield % |
|---|---|---|---|---|---|---|
| BUY | $38.2M | NA | -0.9 | 0.00% | NA | |
| BUY | $46.2B | 675.69% | NA | 0.00% | NA | |
| BUY | $138.8B | 170.45% | 31.92 | 86.04% | NA | |
| BUY | $57.0B | -63.37% | -7.98 | -12.57% | NA | |
| BUY | $85.8B | 17.94% | 19.9 | 84.86% | 0.44% |
Stock Returns calculator for Context Therapeutics Stock including INR - Dollar returns
The Context Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Investment Value
₹1,00,000
Context Therapeutics investment value today
Current value as on today
₹49,031
Returns
Returns from Context Therapeutics Stock
Dollar Impact
₹3,793 (+3.79%)
Analyst Recommendation on Context Therapeutics Stock
Based on 7 analysts
85.71%
Buy
14.29%
Hold
0.00%
Sell
Based on 7 analysts, 85.71428571428571% of analysts recommend a 'BUY' rating for Context Therapeutics. Average target price of $4.25
Context Therapeutics Share Price Target
Get share price movements and forecasts by analysts on Context Therapeutics.
What analysts predicted
91.06%UPSIDE
Target Price
$4.25
Current Price
$0.38
Analyzed by
7 Analysts
Target
$4.25
Context Therapeutics target price $4.25, a slight upside of 91.06% compared to current price of $0.38. According to 7 analysts rating.
Indian Investors' Interest in Context Therapeutics Stock
Search interest for Context Therapeutics Stock has decreased by -12% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Context Therapeutics Quarterly Profit & Loss
All numbers in Millions USD
Context Therapeutics Annual Profit & Loss
All numbers in Millions USD
Context Therapeutics Quarterly Cash Flow
All numbers in Millions USD
Context Therapeutics Annual Cash Flow
All numbers in Millions USD
Insights on Context Therapeutics
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
NO EFFECTAgainst Peers
In the last 3 years, Revolution Medicines, Inc. Common Stock has given 22.0% return, outperforming this stock by 84.7%
- NO EFFECT
Against Peers
In the last 1 year, Moderna, Inc. Common Stock has given 472.8% return, outperforming this stock by 527.1%
NEGATIVE IMPACTPrice Dip
In the last 7 days, CNTX stock has moved down by -17.6%
About Context Therapeutics
| Organisation | Context Therapeutics |
| Headquarters | 2001 Market Street, Philadelphia, PA, United States, 19103 |
| Industry | Biotechnology |
| CEO | Mr. Martin A. Lehr |
| E-voting on shares | Click here to vote |
Key Management of Context Therapeutics
Name | Title |
|---|---|
Mr. Martin A. Lehr | Co-Founder, President, CEO & Director |
Ms. Jennifer Minai-Azary | CFO & Treasurer |
Mr. Alex C. Levit Esq., J.D. | Chief Legal Officer & Corporate Secretary |
Mr. Christopher Beck M.B.A. | Senior Vice President of Operations |
Mr. Jeffrey Liebman | Associate Director of Accounting |
Ms. Jennifer Dashnau M.B.A., Ph.D. | Senior Vice President of Technical Operations |
Dr. Karen Chagin M.D. | Chief Medical Officer |
FAQs
What is Context Therapeutics share price today?
Context Therapeutics share price today is $0.38 as on at the close of the market. Context Therapeutics share today touched a day high of $0.42 and a low of $0.38.
What is the 52 week high and 52 week low for Context Therapeutics share?
Context Therapeutics share touched a 52 week high of $3.62 on and a 52 week low of $0.38 on . Context Therapeutics stock price today i.e. is closed at $0.38,which is 89.50% down from its 52 week high and -0.18% up from its 52 week low.
What is Context Therapeutics's market capitalisation today?
Context Therapeutics market capitalisation is $0.00T as on .
How to invest in Context Therapeutics Stock (CNTX) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Context Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Context Therapeutics Shares that will get you 3.9474 shares as per Context Therapeutics share price of $0.38 per share as on August 29, 2026 at 8:45 am IST.
What is the minimum amount required to buy Context Therapeutics Stock (CNTX) from India?
Indian investors can start investing in Context Therapeutics (CNTX) shares with as little as ₹95.38 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹953.80 in Context Therapeutics stock (as per the Rupee-Dollar exchange rate as on ).
Based on Context Therapeutics share’s latest price of $0.38 as on August 29, 2026 at 8:45 am IST, you will get 26.3158 shares of Context Therapeutics. Learn more about
fractional shares .